These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17577324)

  • 1. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
    Mahomed F; Altini M; Meer S
    Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in immunoexpression of E-cadherin and beta-catenin in oral squamous cell carcinoma with and without nodal metastasis.
    Lopes FF; da Costa Miguel MC; Pereira AL; da Cruz MC; de Almeida Freitas R; Pinto LP; de Souza LB
    Ann Diagn Pathol; 2009 Feb; 13(1):22-9. PubMed ID: 19118778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
    Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
    J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
    Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
    Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
    Wang X; Zhang J; Fan M; Zhou Q; Deng H; Aisharif MJ; Chen X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):547-54. PubMed ID: 19327640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.
    De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F
    APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-catenin expression pattern in primary oral squamous cell carcinoma.
    Cai ZG; Shi XJ; Gao Y; Wei MJ; Wang CY; Yu GY
    Chin Med J (Engl); 2008 Oct; 121(19):1866-70. PubMed ID: 19080115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
    Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
    Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
    Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Yokomakura N; Ishigami S; Aikou T
    J Surg Oncol; 2007 Feb; 95(2):148-55. PubMed ID: 17262732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
    Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
    Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.